Edgar Jackson
Psychiatry · Milwaukee, WINPI 1598833410
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 296 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 296 payments — averaging $16.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Vanda Pharmaceuticals Inc.$1K
- Lundbeck LLC$525
- Otsuka America Pharmaceutical, Inc.$449
- Alkermes, Inc.$269
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$268
- plus $1K from 15 others
What the payments were for
- Food & beverage$4,792100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 87 | $1,091 |
| Vanda Pharmaceuticals Inc. | 55 | $1,032 |
| Lundbeck LLC | 32 | $525 |
| Otsuka America Pharmaceutical, Inc. | 24 | $449 |
| Alkermes, Inc. | 14 | $269 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $268 |
| Supernus Pharmaceuticals, Inc. | 15 | $209 |
| Johnson & Johnson | 18 | $208 |
| Indivior Inc. | 5 | $135 |
| Teva Pharmaceuticals USA, Inc. | 7 | $120 |
| Almatica Pharma LLC | 5 | $120 |
| Noven Therapeutics, LLC | 6 | $85 |
| Neurocrine Biosciences, Inc. | 5 | $79 |
| Axsome Therapeutics, Inc. | 2 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Sunovion Pharmaceuticals Inc. | 2 | $31 |
| Eisai Inc. | 1 | $20 |
| Shire North American Group Inc | 1 | $19 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| AstraZeneca | 1 | $12 |
How this compares
$4,792 in reported general payments places this provider in the 90th percentile of 543 psychiatry providers in Wisconsin.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 15 | $137,517 |
| VraylarCariprazine Hcl | 60 | $95,265 |
| Lurasidone Hcl | 19 | $23,550 |
| TrintellixVortioxetine Hydrobromide | 13 | $5,891 |
| Quetiapine Fumarate | 110 | $1,675 |
| Ziprasidone Hcl | 58 | $1,596 |
| Aripiprazole | 75 | $1,395 |
| Olanzapine | 58 | $1,349 |
| Risperidone | 48 | $1,267 |
| Vilazodone Hcl | 12 | $1,213 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 31 | $1,149 |
| Trazodone Hcl | 131 | $1,059 |
| Zolpidem Tartrate | 133 | $894 |
| Bupropion XlBupropion Hcl | 60 | $885 |
| Clonazepam | 72 | $848 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $79 | $137,51715 claims |
| AbbVieVraylar | $1,091 | $95,26560 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $40 | $5,89113 claims |
| Almatica Pharma LLCSertraline Hcl | $120 | $7532 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 543 psychiatry providers in Wisconsin.
Other psychiatry in Milwaukee
- Thomas IlicMilwaukee$324K
- Jay WinstonMilwaukee$238K
- Joseph BurgarinoMilwaukee$111K
- Jacob BehrensMilwaukee$94K
- Selahattin KurterMilwaukee$17K
- Harold HarschMilwaukee$8K
- Ajay SehgalMilwaukee$7K
- James WinstonMilwaukee$7K
- Ali ArtarMilwaukee$5K
- Robert RuskiewiczMilwaukee$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.